CompanyDrug

Hansoh Pharmaceutical’s Generic Ibrance Approved by NMPA

CompanyDigital

Alibaba Health’s 2022 Financial Report Shows Revenue Growth, Net Loss

CompanyPolicy / Regulatory

Wuxi Biologics Set to Be Removed from US Restricted Trade List

Policy / RegulatoryR&D

CDE Releases 60th Batch of Chemical Generic Reference Preparations

CompanyDeals

Beijing Tianshi Tongda Raises RMB 140M for Autoimmune Disease Therapies

CompanyDeals

Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development

CompanyDeals

Shandong Xinhua Pharmaceutical Inks Tech Transfer Deal for LXH-2201 with IMM

Drug

Shionogi Files NDA for S-217622 COVID-19 Antiviral Drug in China

CompanyDrug

InnoCare Pharma’s ICP-490 Receives NMPA Approval for Hematological Malignancies

CompanyDrug

Hrain Biotech and Novartis Receive Breakthrough Therapy Designations for CAR-T and Zolgensma

CompanyDeals

Techbank Medical Closes RMB 100M Series A to Build Global Innovation Platform

CompanyDeals

PackGene and Genemagic Partner on AAV Production and CDMO Services